SOLENTIM

Advanced Instruments is a global provider of scientific and analytical solutions for the bioprocessing and clinical industries. Solentim, now part of Advanced Instruments, is the trusted global leader for solutions to create, isolate, and characterise the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells.

The Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development (CLD) workflows.  For our customers, which include most of the world’s leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production.

Our customers develop new bio-therapeutics (such as monoclonal antibodies) used to treat a variety of diseases including cancer, auto-immune diseases, cardiovascular disease and many others.  The establishment and reliable continued production of stable ‘cell lines’, originally derived from a single cell (‘Clonally derived’), is a crucial element to these workflows.

Our products play a key role in the CLD workflow, isolating single cells, evidencing that this has been successfully achieved, and subsequently monitoring cell growth.  By streamlining this process, our technology makes CLD workflows shorter, more effective, intelligent and reliable.

Our portfolio of proven and innovative instruments are designed for single cell cloning and assurance of monoclonality.  Combined with enabling reagents and our unparalleled domain expertise, we transform the speed and efficiency of clonally-derived Master Cell Bank development.  Our customers trust in our technology to ensure they are confidently prepared for regulatory review.